Načítá se...
Endometrial Profile of Tamoxifen and Low-dose Estradiol Combination Therapy
PURPOSE: Combination estrogen+progestin therapy has been associated with increased breast cancer risk in postmenopausal women. Selective estrogen receptor modulators (SERMs) are potential alternatives to progestins, although endometrial safety of estrogen+SERM co-therapies is not known. The goal of...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2818660/ https://ncbi.nlm.nih.gov/pubmed/20103679 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-1541 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|